Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. May 7, 2009; 15(17): 2132-2138
Published online May 7, 2009. doi: 10.3748/wjg.15.2132
Published online May 7, 2009. doi: 10.3748/wjg.15.2132
Table 1 Demographic, laboratory and histological features of 124 patients (mean ± SD)
Variable | |
Mean age (yr) | 53.3 ± 1.2 |
Age (yr), n (%) | |
≤ 50 | 51 (41.2) |
> 50 | 73 (58.8) |
Sex, n (%) | |
Male | 90 (72.5) |
Female | 34 (27.5) |
BMI (kg/m2) | |
< 25 | 74 (59.6) |
25-29.9 | 50 (40.3) |
ALT-UNL | 3.0 ± 1.0 |
AST-UNL | 2.0 ± 1.0 |
GGT-UNL | 2.0 ± 0.3 |
Ferritin (ng/mL) | 799.7 ± 75.6 |
Serum iron (&mgr;g/dL) | 126 ± 6.3 |
Platelet count × 103/cmm | 186 ± 74.33 |
HOMA score | 3.48 ± 1.80 |
Steatosis | 92 (74.2) |
Etiology | |
Anti-HCV | 53 (42.7) |
NAFLD | 35 (28.2) |
NAFLD/diabetes | 11 (8.8) |
NASH | 11 (8.8) |
Cryptogenic | 14 (11.3) |
Histology (54) | |
Chronic hepatitis C | 27 (50) |
Cirrhosis cryptogenic | 9 (16.6) |
NAFLD | 7 (12.9) |
NASH | 11 (20.3) |
HFE mutations | 53 (42.7) |
H63D heterozygous | 49 (39.5) |
C282Y heterozygous | 2 (1.6) |
C282Y/H63D compound het | 2 (1.6) |
Table 2 Univariate analysis of risk factors for absent/present liver steatosis in 124 patients with high serum level ferritin
Variable | Steatosis | P value | |
Absent (n = 32) | Present (n = 92) | ||
Age (yr) | 50.9 ± 3.1 | 54.2 ± 1.3 | 0.06 |
Sex | 18 (56.2) | 72 (78.2) | 0.14 |
BMI (kg/m2) | 24.4 ± 3.2 | 25.2 ± 3.1 | 0.30 |
ALT-UNL | 47.7 ± 7.7 | 117.5 ± 11.2 | 0.1 |
AST-UNL | 35.7 ± 5.3 | 89 ± 10.8 | 0.3 |
GGT | 93.1 ± 20.7 | 174.1 ± 19.7 | 0.03 |
Anti-HCV positivity | 24 (75) | 28 (30.4) | 0.02 |
Ferritin (ng/mL) | 464 ± 183 | 1060.8 ± 79 | 0.0006 |
Serum Iron (&mgr;g/dL) | 96.3 ± 7.5 | 137 ± 7.7 | 0.8 |
Platelet count × 103/cmm | 217.8 ± 16.1 | 176.9 ± 8.26 | 0.24 |
HOMA | 3.0 ± 2.25 | 3.5 ± 2.8 | 0.23 |
HFE mutations | 14 (43.7) | 40 (43.4) | 0.63 |
Diabetes | 11 (34.3) | 11 (12) | 0.2 |
Table 3 Predictors of steatosis in 124 patients by logistic regression model
Predictor | Univariate analysis | Multivariate analysis | ||
OR (95% CI) | P value | OR (95% CI) | P value | |
Age (yr) | 0.962 (0.923-1.002) | 0.060 | 0.97 (0.94-1.14) | 0.23 |
Sex | 0.455 (0.160-1.297) | 0.14 | - | - |
BMI (kg/m2) | 1.050 (0.96-1.14) | 0.23 | - | - |
ALT-UNL | 0.997 (0.993-1.001) | 0.12 | - | - |
AST-UNL | 0.998 (0.994-1.002) | 0.36 | - | - |
GGT-UNL | 1.007 (1.001-1.013) | 0.030 | 1.007 (1.003-1.014) | 0.0043 |
Anti-HCV positivity | 0.274 (0.110-0.682) | 0.005 | 0.40 (0.20-1.10) | 0.08 |
Platelet count × 103/cmm | 1.000 (1.000-1.000) | 0.24 | - | - |
Ferritin (ng/mL) | 1.002 (1.001-1.004) | 0.0006 | 1.003 (1.002-1.004) | 0.0009 |
Serum Iron (&mgr;g/dL) | 0.999 (0.991-1.008) | 0.84 | - | - |
HFE mutations | 0.796 (0.313-2.020) | 0.63 | - | - |
Diabetes | 0.995 (0.986-1.004) | 0.28 | - | - |
Table 4 Multivariate analysis of risk factors for high serum ferritin levels in 124 patients by linear regression model
Variable | β | SE | P |
Male | 93.183 | 183.13 | 0.612 |
ALT-UNL | -0.07174 | 1.09734 | 0.948 |
AST-UNL | 1.06027 | 1.05841 | 0.319 |
GGT-UNL | 0.92457 | 0.5746 | 0.111 |
Anti-HCV positivity | 521.964 | 169.40 | 0.0028 |
Platelet count × 103/cmm | -0.00250 | 0.0010 | 0.0161 |
Steatosis | 933.7287 | 180.437 | < 0.0001 |
- Citation: Licata A, Nebbia ME, Cabibbo G, Iacono GL, Barbaria F, Brucato V, Alessi N, Porrovecchio S, Di Marco V, Craxì A, Cammà C. Hyperferritinemia is a risk factor for steatosis in chronic liver disease. World J Gastroenterol 2009; 15(17): 2132-2138
- URL: https://www.wjgnet.com/1007-9327/full/v15/i17/2132.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2132